Literature DB >> 2087298

The level of tryptase in human tears. An indicator of activation of conjunctival mast cells.

S I Butrus1, K I Ochsner, M B Abelson, L B Schwartz.   

Abstract

Tryptase, a neutral endoprotease, is secreted by activated mast cells in human tissues. Tryptase levels in various body fluids have been used as an indicator of mast cell activation. The authors determined tryptase levels in unstimulated tears collected from the following groups of patients: (1) normal control, (2) nonallergic ocular inflammation, (3) asymptomatic seasonal allergic conjunctivitis, (4) symptomatic seasonal allergic conjunctivitis, (5) vernal conjunctivitis, and (6) contact lens-associated giant papillary conjunctivitis. They also assessed the release of tryptase into the tear fluid after provoking the conjunctiva with (7) allergens, (8) compound 48/80, and (9) rubbing. Tryptase levels were elevated in tears of patients with active ocular allergy and also increased after provoking the conjunctiva with allergens in atopic subjects and with compound 48/80 and rubbing in nonatopic subjects. Tryptase levels in tear fluid may prove useful as a clinical indicator of mast cell involvement in ocular allergic disorders. In provocation experiments, tryptase levels may be used to evaluate and compare different mast cell stabilizing agents.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2087298     DOI: 10.1016/s0161-6420(90)32362-x

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  13 in total

Review 1.  Ocular mast cells. Characterization in normal and disease states.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

Review 2.  Conjunctival allergen challenge: models in the investigation of ocular allergy.

Authors:  Mark B Abelson; Oliver Loeffler
Journal:  Curr Allergy Asthma Rep       Date:  2003-07       Impact factor: 4.806

3.  Tryptase concentration in skin blister fluid from patients with bullous skin conditions.

Authors:  K Brockow; D Abeck; K Hermann; J Ring
Journal:  Arch Dermatol Res       Date:  1996-11       Impact factor: 3.017

4.  Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.

Authors:  L B Schwartz; T R Bradford; C Rouse; A M Irani; G Rasp; J K Van der Zwan; P W Van der Linden
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

5.  Anti-inflammatory and antiallergic effects of ketorolac tromethamine in the conjunctival provocation model.

Authors:  A Leonardi; F Busato; I Fregona; M Plebani; A G Secchi
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

6.  Eosinophil cationic protein in tears in allergic conjunctivitis.

Authors:  P G Montan; M van Hage-Hamsten
Journal:  Br J Ophthalmol       Date:  1996-06       Impact factor: 4.638

7.  Characterisation of immune mediator release during the immediate response to segmental mucosal challenge in the jejunum of patients with food allergy.

Authors:  J Santos; C Bayarri; E Saperas; C Nogueiras; M Antolín; M Mourelle; A Cadahia; J R Malagelada
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

8.  Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma.

Authors:  S Bonini; A Lambiase; S Bonini; F Angelucci; L Magrini; L Manni; L Aloe
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 9.  Pathophysiology of ocular allergy: the roles of conjunctival mast cells and epithelial cells.

Authors:  James L Stahl; Ellen B Cook; Neal P Barney; Frank M Graziano
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

10.  Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome.

Authors:  Hyuk Lee; Jung Ho Park; Dong Il Park; Hong Joo Kim; Yong Kyun Cho; Chong Il Sohn; Woo Kyu Jeon; Byung Ik Kim; Seoung Wan Chae
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.